1. Linda-Gail Bekker, South Africa
Award Presentation
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Grant and Fellowship Programmes
Linda-Gail Bekker, South Africa

2. Research Grant Programme
Objectives
Supporting early-stage investigators
Targeted paediatric HIV research in LMICs
Grants
Up to US$75,000 for up to two years ($150,000 maximum)

3. of South Africa, with Stellenbosch University
2017 CIPHER grantee
Amy Louise Slogrove
of South Africa, with Stellenbosch University
Does initiation of antiretroviral therapy prior to immune suppression protect against maternal hypertensive disorders in pregnancy and associated adverse birth outcomes in HIV-infected women?

4. of the United States, with Duke University
2017 CIPHER grantee
Andrew Walker McCrary
of the United States, with Duke University
Evaluating indicators of cardiac function in children living with human immunodeficiency virus

5. of South Africa, with University of Pretoria
2017 CIPHER grantee
Ute Dagmar Feucht
of South Africa, with University of Pretoria
Assessment of factors impacting on fetal and infant immunity and growth in HIV- and antiretroviral-exposed uninfected children

6. Wipaporn Natalie Songtaweesin
2017 CIPHER grantee
Wipaporn Natalie Songtaweesin
of Thailand, with King Chulalongkorn Memorial Hospital
Youth-focused strategies to promote adherence to Pre-Exposure Prophylaxis among youth at risk for HIV in Thailand

7. PAEDIATRIC and ADOLESCENT HIV RESEARCH GRANTS
CIPHER is pleased to launch a new round of
PAEDIATRIC and ADOLESCENT HIV RESEARCH GRANTS
Early-stage investigators
Targeted research in LMICs
Up to US$150,000 for 2 years
Applications open 2 October 2017

8. Growing the Leaders of Tomorrow Fellowship Programme
Objectives
Strengthen paediatric and adolescent HIV clinical research capacity in sub-Saharan Africa
Support junior investigators from SSA
Fellowships
Up to US$35,000 for up to two years (US$ 70,000 maximum)

9. 2017 CIPHER fellow
Adrie Bekker
of South Africa, with Stellenbosch University mentored by Prof Mark F. Cotton
Pharmacokinetic and safety characteristics of nevirapine and lopinavir/ritonavir in HIV-exposed and infected low birth weight infants

10. Namangolwa Jane Mutanga
2017 CIPHER fellow
Namangolwa Jane Mutanga
of Zambia, with Macha Research Trust mentored by Prof Philip Thuma
Long term health outcomes and survival of perinatally HIV-exposed children in Zambia: Designing a comprehensive model of care for long term follow-up